Petros pharmaceuticals announces capital raise of $15 million

Provides update on progress toward over the counter (non-prescription) development of stendra new york, ny / accesswire / july 13, 2023 / petros pharmaceuticals, inc. (nasdaq:ptpi) ("petros" or "the company"), a pioneer in expanding consumer access to medication through the over the counter (otc) pathway, today announces a $15 million private placement financing that will support its continued progress towards bringing its erectile dysfunction (ed) drug, stendra, to non-prescription otc status. petros raised $15 million from this private placement, which was led by its largest existing shareholders.
PTPI Ratings Summary
PTPI Quant Ranking